Author: Schulman Miriam
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.4, Iss.4, 2003-07, pp. : 507-508
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
AAV-2: how can the capsid be modified to improve the viral vector in gene therapy?
Future Virology, Vol. 5, Iss. 2, 2010-03 ,pp. :
Gene therapy - the dynamics of patenting worldwide
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 2, 1998-02 ,pp. :
Analysis of patenting within gene therapy
By Nelson J.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. :